Connect with us

News

Monkeypox: History, Symptoms, Vaccine, Treatment

Published

on

It is a viral zoonotic infection that can spread from animals to humans, however, it is also contagious among humans.SNS:With over 16,000 cases and five deaths being reported from around 75 countries due to Monkeypox, the World Health Organisation (WHO) on Saturday finally declared the outbreak a global health emergency. Meanwhile, four cases have been reported in India, one from Delhi and the other three from Kerala. 

Here’s all you need to know about the virus, its symptoms, treatment, history, etc.

What is Monkeypox?

Monkeypox is an illness caused by a virus of the same name. It is a viral zoonotic infection that can spread from animals to humans, however, it is also contagious among humans. This virus is transmitted via direct or indirect contact through infectious skin or lesions, face-to-face and skin-to-skin contacts, and the exchange of respiratory droplets.

Monkeypox virus is part of the variola virus family of viruses, the same virus that causes smallpox. Its symptoms are similar to that of smallpox but milder, and it is rarely fatal and is not related to chickenpox.

History

A viral infection resembling smallpox was first detected in humans in 1970. Monkeypox is less dangerous and contagious than smallpox, which was eradicated in 1980.According to a study of 528 people in 16 countries published in the New England Journal of Medicine, ninety-five percent of Monkeypox infections have been transmitted through sexual activity.

The disease is called Monkeypox because it was first identified in colonies of monkeys and kept for research in 1958. It was only later detected in humans in 1970.Monkeypox primarily occurs in central and west Africa, in areas with proximity to tropical rainforests, and has been increasingly appearing in urban areas. Animal hosts include a range of rodents and non-human primates.

Symptoms

Monkeypox can cause a range of signs and symptoms.  While some people have mild symptoms, others may develop more serious symptoms and need care in a health facility.Those at higher risk for severe disease or complications include pregnant women, children and people who are immunocompromised.

The most common symptoms of monkeypox include fever, headache, muscle aches, back pain, low energy, and swollen lymph nodes. This is followed or accompanied by the development of a rash which can last for two to three weeks. The rash can be found on the face, palms of the hands, soles of the feet, eyes, mouth, throat, groin, and genital and/or anal regions of the body.

The number of lesions can range from one to several thousand. Lesions begin flat, then fill with liquid before they crust over, dry up and fall off, with a fresh layer of skin forming underneath.

Symptoms typically last two to three weeks and usually go away on their own or with supportive care, such as medication for pain or fever. People remain infectious until all of the lesions have crusted over, the scabs fallen off and a new layer of skin has formed underneath.Anyone who has symptoms that could be monkeypox or who has been in contact with someone who has monkeypox should call or visit a health care provider and seek their advice.

Vaccine

WHO recently approved a vaccine for the prevention of Monkeypox. Some countries are recommending vaccination for persons at risk. Many years of research have led to the development of newer and safer vaccines for an eradicated disease called smallpox, which may also be useful for Monkeypox. Only people who are at risk (for example someone who has been in close contact with someone who has the virus) should be considered for vaccination. Mass vaccination is not recommended at this time.

Treatment

The WHO recommends that people with monkeypox should follow the advice of their health care provider. Symptoms normally resolve on their own without the need for treatment. If needed, medication for pain (analgesics) and fever (antipyretics) can be used to relieve some symptoms.

It is important for anyone with monkeypox to stay well-hydrated, eat well, and get enough sleep. People who are self-isolating should take care of their mental health by doing things they find relaxing and enjoyable, staying connected to loved ones using technology, exercising if they feel well enough, and can do so while isolating.

People with monkeypox should avoid scratching their skin and take care of their rash by cleaning their hands before and after touching lesions and keeping skin dry and uncovered (unless they are unavoidably in a room with someone else, in which case they should cover it with clothing or a bandage until they are able to isolate again). The rash can be kept clean with sterilised water or antiseptic.

Saltwater rinses can be used for lesions in the mouth, and warm baths with baking soda and Epsom salts can help with lesions on the body. Lidocaine can be applied to oral and perianal lesions to relieve pain.Many years of research on therapeutics for smallpox have led to development of products that may also be useful for treating monkeypox.  An antiviral that was developed to treat smallpox (tecovirimat) was approved in January 2022 by the European Medicines Agency for the treatment of monkeypox.

 



Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

Sri Lanka faces new grid challenge as rooftop solar surges: former CEB GM

Published

on

BY IfhAm NIzAm

Sri Lanka could soon face a new electricity-grid challenge—not from too little power, but from having too much solar generation in the wrong places and at the wrong times, a former Ceylon Electricity Board (CEB) General Manager told The Island.

The former CEB GM who insisted not to be named warned that the rapid growth of rooftop and utility-scale solar could place increasing pressure on CEB and LECO distribution feeders, substations and the national grid unless transmission, storage and grid-management systems are upgraded at the same pace.

“The issue is no longer simply how much solar we can install. The question is whether the grid can absorb those electrons when and where they are produced,” he told The Island.

He said Sri Lanka should learn from China and India, where the enormous expansion of renewable generation is now forcing policymakers to focus increasingly on storage, transmission capacity, intelligent dispatch and grid flexibility.

“China has already exceeded 1.28 TW of installed solar, while India’s grid-connected installed solar capacity stood at around 162.15 GW as of June 30, 2026. The difficult question now is what you actually do with so much solar when everyone is generating at almost the same time,” he said.

For Sri Lanka, he said, the warning is particularly relevant to the distribution network.

A feeder carrying a high concentration of rooftop solar can, during periods of strong sunshine and low local demand, move from the traditional one-way flow of electricity towards consumers to reverse power flow back towards the transformer and upstream network.

“That means the feeder is no longer simply a one-way road for electricity. At certain times of the day, it becomes a two-way road,” he said.

This can create voltage-rise, protection-coordination and transformer-loading issues and could eventually limit the amount of additional rooftop solar that can safely be connected to particular feeders.

“What matters is where those megawatts are connected,” he told The Island.

He said Sri Lanka therefore needs to begin looking at solar hosting capacity feeder by feeder and substation by substation, rather than treating the national grid as having unlimited capacity to absorb new distributed generation.

The problem is compounded by the evening transition, when solar generation falls rapidly just as electricity demand can increase.

“If the system has a lot of solar in the middle of the day and then loses that generation rapidly in the evening, something else has to respond. That is a flexibility problem,” he said.

This is where battery energy storage systems (BESS) are likely to become increasingly important—but the former CEB chief cautioned against allowing cheap imported battery hardware to drive the market.

“Sri Lanka could soon have huge BESS demand, very cheap battery hardware and everyone suddenly becoming a BESS pundit. What could possibly go wrong?” he said.

He cited fire safety, degradation, poor integration, weak energy-management systems, questionable warranties, incorrect sizing, inappropriate grid locations and poor thermal management as major risks.

“A system can look fantastic in Excel on Day One but perform very differently in Year Two,” he told The Island.

He said the future BESS market would therefore be determined less by who could supply the cheapest container and more by who understood the complete system.

“The future BESS business will not be about who can assemble the cheapest container. It will be about who understands battery, PCS, EMS, grid, safety, degradation and dispatch economics as one system,” he said.

For Sri Lanka, storage should also be considered as a distribution-grid asset, rather than solely as a large transmission-level installation.

Strategically located batteries could absorb excess rooftop solar on constrained feeders during the middle of the day and release electricity later when local demand rises, potentially reducing network congestion and improving the value of distributed generation.

“The question is not simply, ‘How many megawatt-hours of batteries do we need?’ The question is, ‘Where does the battery create the greatest system value?’” he said.

He said China’s and India’s experience could broadly be viewed as three stages: Phase One—build solar and wind; Phase Two—build storage; and Phase Three—redesign the grid around renewables.

Sri Lanka, he said, should learn from that progression before renewable penetration makes grid problems significantly more expensive to solve.

“Installing another large amount of solar is one thing. Absorbing those electrons when the sun is shining everywhere at once is quite another,” he said.

“Solar taught us how to generate cheap electrons. BESS and the grid will decide whether those cheap electrons are actually useful when they are needed.”

“That is perhaps the biggest lesson Sri Lanka should take from China and India’s energy transition right now,” he added.

Continue Reading

News

SC rules President Sirisena’s pardon of Gnanasara thera invalid

Published

on

The Supreme Court yesterday ruled that former President Maithripala Sirisena’s decision to grant a presidential pardon to Bodu Bala Sena (BBS) General Secretary Ven. Galagoda Atte Gnanasara Thera was arbitrary and invalid in law.

A three-judge bench headed by Justice Janak de Silva delivered the judgment in response to fundamental rights petitions filed by the Centre for Policy Alternatives (CPA) and Sandhya Ekneligoda, challenging the former President’s decision to release the monk from prison.

Gnanasara Thera had been sentenced by the Court of Appeal in August 2018 to 19 years’ rigorous imprisonment, to run concurrently as six years, after being found guilty of contempt of court over his conduct inside the Homagama Magistrate’s Court on January 25, 2016, during proceedings related to the disappearance of Prageeth Ekneligoda.

The Supreme Court subsequently upheld the Court of Appeal’s finding of guilt on October 5, 2018.

However, Gnanasara Thera was released from Welikada Prison on May 23, 2019, after the then President Sirisena granted him a presidential pardon.

The petitioners challenged the legality of the pardon, prompting the Supreme Court to examine the exercise of the President’s constitutional power of clemency.

The Court’s ruling yesterday effectively nullifies the pardon granted to the BBS leader.

Viran Corea, PC, with Luwie Ganeshathasan and Khyati Wikramanayake appeared for the CPA, while Counsel Asthika Devendra, with Pulasthi Hewamanne, instructed by Manjula Balasuriya, appeared for Sandhya Ekneligoda.Counsel Thishya Weragoda, with Sanjaya Marambe and Iresh Senevirathne, appeared for Gnanasara Thera. Faiszer Musthapha, PC, with Pulasthi Rupesinghe, appeared for former President Sirisena.

Continue Reading

News

Duminda, another indicted in gold-plated T-56 case

Published

on

Duminda Dissanayake

The Colombo High Court yesterday served indictments on former Minister Duminda Dissanayake and a woman in connection with the discovery of a gold-plated T-56 assault rifle at the Havelock City apartment complex in Wellawatte.

Following the indictments, the High Court Judge ordered that both accused be released on bail.

Court records indicate that indictments had also been filed against Dissanayake and the same co-accused on September 9, after which they were granted bail.

The case relates to the discovery of the gold-plated firearm at the apartment complex in May 2025.

Two women, aged 40 and 68, were initially arrested in connection with the possession of the weapon, before the investigation was handed over to the Terrorism Investigation Division (TID).

Subsequent investigations by the TID led to Dissanayake being arrested and produced before court. However, he was later released after the Attorney General’s Department informed court that there was insufficient evidence at the time to proceed with legal action against him.

Continue Reading

Trending